// App-Quantinova.ai

1829 : The validation of a pyrosequencing KRAS mutation detection assay

Researchers

Presenter

  • Matthew L. Poulin

Principal Investigators

  • Ann Meyer

  • E. Andrew Mead

  • Jessica Xu

  • Ryan Drennan

  • Liyin Yan

Medical Centers

  • EpigenDx, Inc., Hopkinton, MA.

Locations

  • United States

Companies

  • EpigenDx, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Lympho proliferative disease

Biomarkers

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved